©The Author(s) 2025.
World J Diabetes. Dec 15, 2025; 16(12): 111771
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.111771
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.111771
Figure 3 Comparison of zonulin and zonula occludens-1 expression in the colons of the mice in each group.
A: Colonic zonula occludens-1 (ZO-1) expression histogram for the mice in each group (n = 10); B: Colonic zonulin expression histogram for the mice in each group (n = 10); C: Correlation analysis between ZO-1 and zonulin in the colon (n = 30). bP < 0.01 vs negative control group. cP < 0.001 vs negative control group. fP < 0.001 vs streptozotocin-induced type 1 diabetes mellitus group. NC group: Negative control group; STZ group: Streptozotocin-induced type 1 diabetes mellitus group; A. muciniphila group: Akkermansia muciniphila intervention group; ZO-1: Zonula occludens-1.
- Citation: Huang BJ, Guo S, Lin XY, Li YH, Ma HM, Zhang J, Chen QL. Oral Akkermansia muciniphila may ameliorates immune dysregulation in a murine model of streptozotocin-induced type 1 diabetes. World J Diabetes 2025; 16(12): 111771
- URL: https://www.wjgnet.com/1948-9358/full/v16/i12/111771.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i12.111771